Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Joseph McClellan
Person

Joseph McClellan

Tracked across 1 events · 11 articles · First seen Jun 08, 2026 · Last active Jun 08, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Regulatory
Alvotech AVT16 BLA accepted by U.S. Food and Drug Administration
Alvogen>>> announced that the United States — Food and Drug Administration>>> has accepted for review its Biologics License Application (BLA) for AVT16. AVT16 is a proposed interchangeable biosimilar to Vedolizumab (vedolizumab), a biologic medicine used…
Impact: Joseph McClellan>>>, COO of Alvogen>>>, commented on the significance of the FDA's acceptance of the BLA for AVT16.
Jun 08, 2026 · 11 articles
NEWSDESK
Track Joseph McClellan live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.